Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Influenza Testing Market: By Test Type, Product, Type-of-Flu, End User, and Geography and forecast to 2030
Influenza Testing Market was valued at US$ 2,673.3 million in 2023 and is expected to grow at an 6.1% CAGR from 2024 to 2030. Influenza is a communicable flu that is caused by a virus and spreads when people come in contact with the affected person. Influenza testing is generally done to check the main reason for the disease and proper diagnosis is being started to cure the patient. The growing incidence of influenza diseases due to the influenza virus and rising demand for rapid disease diagnosis are the significant factors responsible for driving the growth of the influenza testing market. For instance, in September 2022, National Influenza Centres and other laboratories from 102 countries tested over 112,017 specimens between 22nd August 2022 to 4th September 2022. Out of those, 3,879 tested positive for influenza viruses. Additionally, the increasing focus on quality of healthcare along with the growing concern of faster diagnosis and influenza control also heighten the overall growth of the influenza testing market.
However, factors such as the high cost included in influenza testing procedures obstruct the influenza testing market’s growth in the forecast period. On the other hand, the stringent regulatory framework has the potential to challenge the influenza testing market. Furthermore, the growth in influenza research for diagnostic technologies is expected to generate profitable opportunities for the influenza testing market. Moreover, the growing availability of point-of-care testing (POCT) in the area of rapid diagnostics of infectious diseases including flu, is expected to increase the demand for influenza testing in developing countries. For instance, a study was conducted in October 2022, to assess the POCT scope for infectious diseases in European countries. As per the study, under surveillance, POCT is widely used for infectious diseases with significant incidence rates, such as HIV and flu. Clinical research funding and expenditures in this field help to increase the scope of the projects that are done as well as the number of people engaged. Governments, the private sector, and businesses all provide money for research and development. For instance, in September 2019, the Collaboration Influenza Vaccine Innovations Centers (CIVICs) programme was launched by the National Institute of Allergy and Infectious Diseases (NIAID), a division of National Institutes of Health.
Recent Market Developments:
Study Period
2024– 2030Base Year
2023CAGR
6.1%Largest Market
North AmericaFastest Growing Market
Asia pacific
Increasing healthcare expenditure and the availability of effective treatment options have led to an increase in the median age worldwide. The WHO, CDC, and European Centre for Disease Prevention and Control, among other regulatory bodies, are actively recording incidence & prevalence data to counter the disease systematically. These bodies work together with local governments to achieve overall control of the treatment and management of this disease. The Global Influenza Program (GIP) is one initiative the WHO undertook to provide technical support, strategic guidance, and coordination activities concerning zoonotic, pandemic, and seasonal flu cases. Such initiatives are expected to boost market growth during the forecast period.
Report Benchmarks |
Details |
Report Study Period |
2024– 2030 |
Market Size in 2023 |
US$ 2,673.3 million |
Market CAGR |
6.1% |
By Test Type |
|
By Product |
|
By Type-of-Flu |
|
By End User |
|
Download Free Sample Report
Influenza Testing Market was valued at US$ 2,673.3 million in 2023 and is expected to grow at an 6.1% CAGR from 2024 to 2030.
3M Company, Abbott Laboratories, Becton, Dickinson and Company (BD), and Meridian Bioscience, Inc. are some of the major players operating in the influenza testing market.
Asia Pacific is estimated to grow at the highest CAGR over the forecast period.
North America accounts for the largest market share and is expected to be the primary market driver in the influenza testing market
High costs included in influenza testing procedures and stringent regulatory framework are expected to limit the growth of the influenza testing market.
1. Executive Summary |
2. Global Influenza Testing Market Introduction |
2.1.Global Influenza Testing Market - Taxonomy |
2.2.Global Influenza Testing Market - Definitions |
2.2.1.Test Type |
2.2.2. Product |
2.2.3.Type-of-Flu |
2.2.4.End Users |
2.2.5.Region |
3. Global Influenza Testing Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4. Global Influenza Testing Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Influenza Testing Market By Test Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
5.1. Traditional Diagnostics Tests |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Molecular Diagnostics Tests |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
6. Global Influenza Testing Market By Product, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
6.1. Point-Of-Care Testing |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Immunodiagnostics |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Molecular Diagnostics |
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
7. Global Influenza Testing Market By Type-of-Flu, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
7.1. Type A Flu |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Type B Flu |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Type C Flu |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
8. Global Influenza Testing Market By End Users, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
8.1. Hospitals |
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Clinical Laboratories |
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Reference Laboratories |
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Other End Users |
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
9. Global Influenza Testing Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
9.1. North America |
9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.1.3. Market Opportunity Analysis |
9.2. Europe |
9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.2.3. Market Opportunity Analysis |
9.3. Asia Pacific (APAC) |
9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.3.3. Market Opportunity Analysis |
9.4. Middle East and Africa (MEA) |
9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.4.3. Market Opportunity Analysis |
9.5. Latin America |
9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.5.3. Market Opportunity Analysis |
10. North America Influenza Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
10.1. Test Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Traditional Diagnostics Tests |
10.1.2.Molecular Diagnostics Tests |
10.2. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Point-Of-Care Testing |
10.2.2.Immunodiagnostics |
10.2.3.Molecular Diagnostics |
10.3. Type-of-Flu Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Type A Flu |
10.3.2.Type B Flu |
10.3.3.Type C Flu |
10.4. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Hospitals |
10.4.2.Clinical Laboratories |
10.4.3.Reference Laboratories |
10.4.4.Other End Users |
10.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.5.1.United States of America (USA) |
10.5.2.Canada |
11. Europe Influenza Testing Market,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
11.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Traditional Diagnostics Tests |
11.1.2.Molecular Diagnostics Tests |
11.2. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Point-Of-Care Testing |
11.2.2.Immunodiagnostics |
11.2.3.Molecular Diagnostics |
11.3. Type-of-Flu Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Type A Flu |
11.3.2.Type B Flu |
11.3.3.Type C Flu |
11.4. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.Hospitals |
11.4.2.Clinical Laboratories |
11.4.3.Reference Laboratories |
11.4.4.Other End Users |
11.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.5.1.Germany |
11.5.2.France |
11.5.3.Italy |
11.5.4.United Kingdom (UK) |
11.5.5.Spain |
11.5.6.Rest of EU |
12. Asia Pacific (APAC) Influenza Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
12.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Traditional Diagnostics Tests |
12.1.2.Molecular Diagnostics Tests |
12.2. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Point-Of-Care Testing |
12.2.2.Immunodiagnostics |
12.2.3.Molecular Diagnostics |
12.3. Type-of-Flu Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Type A Flu |
12.3.2.Type B Flu |
12.3.3.Type C Flu |
12.4. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.Hospitals |
12.4.2.Clinical Laboratories |
12.4.3.Reference Laboratories |
12.4.4.Other End Users |
12.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.5.1.China |
12.5.2.India |
12.5.3.Australia and New Zealand (ANZ) |
12.5.4.Japan |
12.5.5.Rest of APAC |
13. Middle East and Africa (MEA) Influenza Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
13.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Traditional Diagnostics Tests |
13.1.2.Molecular Diagnostics Tests |
13.2. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Point-Of-Care Testing |
13.2.2.Immunodiagnostics |
13.2.3.Molecular Diagnostics |
13.3. Type-of-Flu Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Type A Flu |
13.3.2.Type B Flu |
13.3.3.Type C Flu |
13.4. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Hospitals |
13.4.2.Clinical Laboratories |
13.4.3.Reference Laboratories |
13.4.4.Other End Users |
13.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.5.1.GCC Countries |
13.5.2.South Africa |
13.5.3.Rest of MEA |
14. Latin America Influenza Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
14.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.1.1.Traditional Diagnostics Tests |
14.1.2.Molecular Diagnostics Tests |
14.2. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.2.1.Point-Of-Care Testing |
14.2.2.Immunodiagnostics |
14.2.3.Molecular Diagnostics |
14.3. Type-of-Flu Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.3.1.Type A Flu |
14.3.2.Type B Flu |
14.3.3.Type C Flu |
14.4. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.4.1.Hospitals |
14.4.2.Clinical Laboratories |
14.4.3.Reference Laboratories |
14.4.4.Other End Users |
14.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.5.1.Brazil |
14.5.2.Mexico |
14.5.3.Rest of LA |
15. Competition Landscape |
15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
15.2.1.3M Company |
15.2.2.Abbott Laboratories |
15.2.3.Becton, Dickinson and Company (BD) |
15.2.4.Meridian Bioscience, Inc. |
15.2.5.Quidel Corporation |
15.2.6.Hoffmann-La Roche Ltd |
15.2.7.SA Scientific Ltd |
15.2.8.SEKISUI Diagnostics |
15.2.9.Thermo Fisher Scientific, Inc. |
15.2.10.Hologic, Inc. |
16. Research Methodology |
17. Appendix and Abbreviations |
Key Market Players